SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Amyris, Inc. (AMRS) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 16/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AMRS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.06
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.58
Book Value / Share$0.00
Revenue / Share$0.80
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-46.73 |
$41.12M |
$-235.11M |
-571.8% |
| 2014 |
$0.28 |
$43.27M |
$2.29M |
5.3% |
| 2015 |
$-25.75 |
$34.15M |
$-217.95M |
-638.2% |
| 2016 |
$-4.95 |
$77.19M |
$-87.33M |
-113.1% |
| 2017 |
$-2.40 |
$143.45M |
$-77.39M |
-54% |
| 2018 |
$-3.50 |
$80.42M |
$-211.35M |
-262.8% |
| 2019 |
$-2.39 |
$152.56M |
$-242.77M |
-159.1% |
| 2020 |
$-1.59 |
$173.14M |
$-324.14M |
-187.2% |
| 2021 |
$-0.90 |
$341.82M |
$-264.2M |
-77.3% |
| 2022 |
$-1.58 |
$269.85M |
$-535.93M |
-198.6% |
